secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001477932-23-005042
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health completes Cana buy for $1.67M; assets valued over $10M, expects gain
--------------------------------------------------------------------------------

- Purchase price $1.67M (€800k cash + $800k stock at $17.25/share) for 100% of Cana; closed June 30, 2023.
- Cana's tangible and intangible assets independently valued >$10M; Cosmos expects substantial gain on bargain purchase.
- Cana's 54,000 sq ft production facility added; prior acquisitions: Bikas GP (>$10M annual revenue) and ZipDoctor.
- Binding LOI for German-based Docpharm; projected to add $30M annual revenue by 2025.
- R&D clinical trials for obesity/weight management scheduled to start Q4 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223005042/0001477932-23-005042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223005042/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-005042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer